Allelverlust von 11q23 als Progressionsmechanismus zur regionären Lymphknotenmetastasierung beim Melanom?

Rudolf Herbst(Helios Klinikum Erfurt), Johannes M. Weiss(University Hospital Ulm), Alexander Kapp(Medizinische Hochschule Hannover), Uta Casper(Medizinische Hochschule Hannover), Joke Schubach(Medizinische Hochschule Hannover), Alexander Ehnis, Susanne Mommert(Medizinische Hochschule Hannover), Edith Podewski(Medizinische Hochschule Hannover)
Unknown
January 1, 2000
10.1007/978-3-642-57191-6_133
Cited by 0

Related Papers

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
The <scp>EAACI</scp>/<scp>GA</scp><sup>2</sup><scp>LEN</scp>/<scp>EDF</scp>/<scp>WAO</scp> Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Allergy|2014|1.2k
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial
|The Lancet Oncology|2016|704
The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Dermatology Review|2015|429